← Leaderboards
Barbara Wegiel
Beth Israel Deaconess Medical Center
$4,886,655
Attributed
$4,886,655
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $764.1K · FY2013–24$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,886,655 · 4
By mechanism
R01$4,030,976 · 2
R21$855,679 · 2
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Maria Serena Longhi$3,119,696
- Fritz H Bach$2,929,318
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationCellsMacrophageMediatingSchemeResponseHemeInflammatoryHeme Oxygenase-1MolecularIn VitroProductionLeadInjuryBiliverdineEnzymesCessation Of LifePatternExtracellularBindingInflammation MediatorsCell DeathIschemiaCatabolism
Grant awards (13)
Characterizing the role of the heme catabolism in tissue damage and inflammation.$502,661
R01 · FY2024 · DK · contact PI
Characterizing the role of the heme catabolism in tissue damage and inflammation.$523,605
R01 · FY2023 · DK · contact PI
Characterizing the role of the heme catabolism in tissue damage and inflammation.$523,605
R01 · FY2022 · DK · contact PI
Determining the role of gas metabolite in response to immunotherapy$240,529
R21 · FY2022 · CA · contact PI
Characterizing the role of the heme catabolism in tissue damage and inflammation.$523,605
R01 · FY2021 · DK · contact PI
Determining the role of gas metabolite in response to immunotherapy$204,531
R21 · FY2021 · CA · contact PI
Role of biliverdin reductase during sterile inflammation in the liver.$391,500
R01 · FY2020 · DK · contact PI
Role of biliverdin reductase during sterile inflammation in the liver.$391,500
R01 · FY2019 · DK · contact PI
Role of biliverdin reductase during sterile inflammation in the liver.$391,500
R01 · FY2018 · DK · contact PI
Role of biliverdin reductase during sterile inflammation in the liver.$391,500
R01 · FY2017 · DK · contact PI
Role of biliverdin reductase during sterile inflammation in the liver.$391,500
R01 · FY2016 · DK · contact PI
Heme degradation pathway and immunomodulation in prostate cancer.$183,549
R21 · FY2014 · CA · contact PI
Heme degradation pathway and immunomodulation in prostate cancer.$227,070
R21 · FY2013 · CA · contact PI